Hereby, Pik3c3f/f;CD4-Cre mice proved to be resistant to experimental autoimmune encephalomyelitis, highlighting the possibility to target CD4+ T cell differentiation for the treatment of inflammatory diseases [34]. Here, CD4 is linked to experimental autoimmune encephalomyelitis.